You are now in:
Euro Durg/Working Groups/HAPPY AUDIT

HAPPY AUDIT

From the University of Southern Denmark, Eurodurg received a request to participate on a project, namely “Health Alliance for Prudent Prescribing, Yield and Use of Antimicrobial Drugs in the Treatment of Respiratory Tract Infections”, coordinated by Prof. Lars Bjerrum (Research Unit of General Practice).

Summary of the project

The aim of the project is to strengthen the surveillance of respiratory tract infections in primary health care in Europe through development of intervention program targeting general practitioners (GPs), parents of young children and healthy adults. The team will study the incidence of respiratory tract infections among patients in general practice and carry out research based on audit registration to explore the existing use of diagnostic tools in patients with respiratory tract infections. Based on results from audit registrations in primary health care, the team will develop locally adapted intervention program, including guidelines, courses for GPs, workshops and patient information leaf-lets for improving the quality of antibiotic prescription. The overall aim of the intervention program is to reduce the occurrence of bacterial resistance by reducing prescribing of unnecessary antibiotics for respiratory tract infections and by improving the use of appropriate antibiotics in suspected bacterial infections.
The proposed method for auditing GPs is called Audit Project Odense (APO). APO has been developed and successfully tested among the different groups of GPs in the Nordic countries. In this project APO will be used at European level involving some 400 GPs from 12 regions with different
cultural back-ground and different organisation of primary health care. Research on the effect of preventive measures will be performed by analysing audit registrations carried out before and after the intervention period. The results will be widely disseminated in a Working Con-ference hosted by the World Association of Family Doctors (P16 WONCA) at the end of the project pe-riod. To ensure public awareness of the risk of resistant bacteria, media campaigns targeting both professionals and the public will be developed and the results, including a guideline for implementing the APO method in primary health care in other countries, will be published.

Contractors:

P01 Research Unit for General Practice in Odense
P02 GP Consultants
P03 Ministry of the Interior and Health
P04 Blekinge Institute for Research and Development
P05 National Board of Health and Welfare
P06 FD Centre
P07 State Patient Fund
P08 Association of Family Doctors, Kaliningrad
P09 College of Family Physicians in Paris
P10 Haute Autorité de la Santé
P11 Spanish Society of Family Medicine
P12 University of Las Palmas de Gran Canaria
P13 Consejería de Sanidad del Gobierno de Canarias
P14 Misiones Association of General Family Medicine and Health Team
P15 World Health Organisation, Collaborating Centre for Drug Statistics Methodology
P16 World Organisation of Family Doctors
P17 European Drug Utilisation Research Group

On behalf of EuroDURG, R. Vander Stichele (former president) has accepted the three selected tasks for EuroDURG’s role in the partnership

• to provide available statistical information from different countries (e.g. use of antibiotics)
• to help organising a 2-day working conference at the end of the 36-month project
• and to contribute in disseminating the results of the project.

Interested researchers or dataproviders can contact
Ria Benko
E-mail: benko@clph.szote.u-szeged.hu

		Euro DURG home page